REVIEW
|
doi:10.20944/preprints202108.0420.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Hodgkin lymphoma, HIV,; antiretroviral therapy; prognosis; etiopathogenesis
Online: 20 August 2021 (14:08:47 CEST)
REVIEW
Subject:
Medicine And Pharmacology,
Immunology And Allergy
Keywords:
Hodgkin lymphoma, HIV; antiretroviral therapy; prognosis; etiopathogenesis
Online: 2 June 2021 (11:53:29 CEST)
REVIEW
|
doi:10.20944/preprints202305.1239.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Hodgkin lymphoma; non-Hodgkin lymphoma; PD1 / PD-L1 checkpoint inhibitors; tumor mutational burden; predictive biomarkers
Online: 17 May 2023 (10:52:16 CEST)
ARTICLE
|
doi:10.20944/preprints202307.1984.v1
Subject:
Medicine And Pharmacology,
Hematology
Keywords:
Cancer-related cognitive impairment; Hodgkin lymphoma; neuropsychology; affective distress; quality of life
Online: 28 July 2023 (09:23:56 CEST)
REVIEW
|
doi:10.20944/preprints201904.0209.v1
Subject:
Biology And Life Sciences,
Immunology And Microbiology
Keywords:
Hodgkin lymphoma; tumor microenvironment; immune escape; tumor-associated macrophages
Online: 18 April 2019 (08:14:50 CEST)
REVIEW
|
doi:10.20944/preprints202403.0892.v2
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Lymphoma; Hodgkin’ s lymphoma; Non-Hodgkin’ s lymphoma; Burkitt lymphoma; gut microbiota; short-chain fatty acids; gut metabolites; postbiotics
Online: 18 March 2024 (09:32:30 CET)
ARTICLE
|
doi:10.20944/preprints202311.0881.v1
Subject:
Biology And Life Sciences,
Cell And Developmental Biology
Keywords:
Hodgkin lymphoma; doxorubicin; drug resistance; cross-resistance; immunosuppression
Online: 14 November 2023 (09:57:04 CET)
REVIEW
|
doi:10.20944/preprints202305.1213.v1
Subject:
Medicine And Pharmacology,
Hematology
Keywords:
Hodgkin lymphoma; tumor microenvironment; tumor associated macrophages; CD169+ macrophages; immune evasion; immunosuppression
Online: 17 May 2023 (09:37:22 CEST)
REVIEW
|
doi:10.20944/preprints202104.0376.v1
Subject:
Medicine And Pharmacology,
Immunology And Allergy
Keywords:
Diffuse large B cell lymphoma; non-Hodgkin lymphoma; apoptosis; genetics; BCL2; NF-kB; TP53; mutations; translocations; amplifications
Online: 14 April 2021 (12:32:31 CEST)
REVIEW
|
doi:10.20944/preprints202408.1069.v1
Subject:
Medicine And Pharmacology,
Hematology
Keywords:
Hodgkin’ s Lymphoma; Brentuximab-AVD; (A+AVD); Visceral leishmaniasis; splenomegaly
Online: 14 August 2024 (13:59:29 CEST)
REVIEW
|
doi:10.20944/preprints202307.0430.v1
Subject:
Medicine And Pharmacology,
Hematology
Keywords:
Hodgkin lymphoma; relapsed/refractory; brentuximab vedotin; checkpoint inhibitor; PD-1 inhibitor; nivolumab; pembrolizumab; autologous hematopoietic cell transplantation
Online: 6 July 2023 (11:44:13 CEST)
REVIEW
|
doi:10.20944/preprints202305.1344.v1
Subject:
Medicine And Pharmacology,
Pathology And Pathobiology
Keywords:
mediastinal gray-zone lymphoma; classical Hodgkin lymphoma; primary mediastinal B-cell lymphoma; diffuse large B-cell lymphoma; NOS; EBV-positive diffuse large B-cell lymphoma; NOS; morphology; phenotype; gene expression profile; mutational landscape
Online: 18 May 2023 (12:25:07 CEST)
CASE REPORT
|
doi:10.20944/preprints202405.1389.v1
Subject:
Medicine And Pharmacology,
Pathology And Pathobiology
Keywords:
hospital fall; delayed splenic rupture; non-hodgkin lymphoma; autopsy; forensic diagnosis; malpractice; immunohistochemistry
Online: 21 May 2024 (12:29:06 CEST)
CASE REPORT
|
doi:10.20944/preprints202404.1067.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Central nervous system (CNS) 1, intracranial lesion 2, Hodgkin lymphoma 3, relapse 4, refractory 5, neuroimaging 6, ring enhancing 7, immunotherapy 8, chemotherapy 9
Online: 16 April 2024 (14:00:25 CEST)
ARTICLE
|
doi:10.20944/preprints202212.0098.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Hodgkin lymphoma; chemotherapy; positron emission tomography computed tomography (PET-CT); fluorodeoxyglucose F18 (18F-FDG); Deauville score; standardized uptake value (SUV); response prediction.
Online: 6 December 2022 (09:55:58 CET)
ARTICLE
|
doi:10.20944/preprints202301.0073.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
metabotropic glutamate 5 receptor; anti-mGluR5 encephalitis; neuroimmunology; pediatric neu-rology; pediatric oncology; transcriptome analysis; Hodgkin lymphoma; Ophelia syndrome
Online: 4 January 2023 (08:47:37 CET)
REVIEW
|
doi:10.20944/preprints202408.0366.v1
Subject:
Medicine And Pharmacology,
Hematology
Keywords:
Hodgkin lymphoma; Reed-Sternberg cell; Nanotechnology; 3D Q-FISH; Telomere/shelterin; TRF2; Lamin A/C; LMP1 oncogene; Breakage-Bridge-Fusion (BBF) cycles; t-stumps
Online: 6 August 2024 (12:35:18 CEST)
CASE REPORT
|
doi:10.20944/preprints201808.0143.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Lymphoproliferative diseases, Hodgkin lymphoma, Chronic Lymphocytic Leukemia, clonality, Hodgkin/Reed–Sternberg cell, Bendamustine
Online: 7 August 2018 (12:02:58 CEST)
ARTICLE
|
doi:10.20944/preprints202409.0628.v1
Subject:
Oncology And Oncogenics,
Medicine And Pharmacology
Keywords:
Hodgkin Lymphoma (HL); Non-Hodgkin Lymphoma (NHL); malignant lymphomas; genetic factors; environmental carcinogenic factors; multifactorial disorders; hereditary
Online: 9 September 2024 (09:21:15 CEST)
ARTICLE
|
doi:10.20944/preprints202201.0162.v1
Subject:
Medicine And Pharmacology,
Pathology And Pathobiology
Keywords:
antibiotic cnsumtion; microbiome; hematological malignancies; Hodgkin-lymphoma (HL); Non-Hodgkin lymphoma (NH); multiplex myeloma (MM); leukemia (LEU)
Online: 12 January 2022 (12:53:22 CET)
ARTICLE
|
doi:10.20944/preprints202403.0299.v1
Subject:
Computer Science And Mathematics,
Mathematical And Computational Biology
Keywords:
Hodgkin-Huxley; Reaction-Diffusion; Synchronization; Complex Systems
Online: 6 March 2024 (10:52:36 CET)
ARTICLE
|
doi:10.20944/preprints202010.0495.v1
Subject:
Medicine And Pharmacology,
Immunology And Allergy
Keywords:
NK cells; UMAP; trogocytosis; AML; Hodgkin lymphoma
Online: 23 October 2020 (15:34:40 CEST)
ARTICLE
|
doi:10.20944/preprints202204.0038.v1
Subject:
Biology And Life Sciences,
Anatomy And Physiology
Keywords:
Goldman-Hodgkin-Katz eq.; Nernst eq.; ion adsorption; membrane potential
Online: 6 April 2022 (08:37:53 CEST)
REVIEW
|
doi:10.20944/preprints202111.0317.v1
Subject:
Biology And Life Sciences,
Biochemistry And Molecular Biology
Keywords:
Non-Hodgkin lymphoma; Epigenetics; DNA methylation; HAT; HDAC; EZH2; bromodomain inhibitors; Drug combination; clinical testing
Online: 17 November 2021 (23:45:00 CET)
REVIEW
|
doi:10.20944/preprints202409.0678.v1
Subject:
Oncology And Oncogenics,
Medicine And Pharmacology
Keywords:
Malignant Lymphomas; Hodgkin Lymphomas (HL); Non-Hodgkin Lymphomas (NHL); B-cell Neoplasms; T-cell Neoplasms; NK-cell Neoplasms; Grey Zone Lymphomas; Epidemiology; Classification; Staging; Histopathology; Radiotherapy; Chemotherapy; Immunotherapy; Treatment Strategies; Remission; Treatment Complications; Personalized Medicine; Innovative Therapies
Online: 9 September 2024 (11:58:11 CEST)
REVIEW
|
doi:10.20944/preprints202112.0518.v1
Subject:
Biology And Life Sciences,
Immunology And Microbiology
Keywords:
B-cell non-Hodgkin lymphoma (B-NHL); B-cell receptor (BCR); Bruton’s tyrosine kinase (BTK); spleen tyrosine kinase (SYK); phosphoinositide-3-kinase (PI3K); ibrutinib; acalabrutinib; copanlisib; idelalisib; umbralisib; fostamatinib; combination therapies
Online: 31 December 2021 (12:23:29 CET)
REVIEW
|
doi:10.20944/preprints202407.1456.v1
Subject:
Medicine And Pharmacology,
Hematology
Keywords:
advanced therapy medicinal products (ATMPs); chimeric antigen receptors (CAR-T cells); B acute lymphoblastic leukaemia (B-ALL); food and drug administration (FDA); systemic lupus erythematosus (SLE); idiopathic inflammatory myositis (IIM); systemic sclerosis (SS); memorial sloan kettering cancer centre (MSKCC); hematopoietic stem cell transplantation [HSCT], non-Hodgkin’ s cell lymphoma (NHCL); multiple myeloma (MM); follicular lymphoma; (FL); large B cell-lymphoma (LBCL); mantle cell lymphoma (MCL); myeloid-derived suppressor cells (MDSCs); rheumatoid arthritis (RA); immune effector cell-associated neurotoxicity syndrome (ICANS); natural killer group member D ligands (NKG2DLs); acute myelogenous leukaemia (AML)
Online: 18 July 2024 (08:03:12 CEST)